Mergers & Acquisitions
By The Online Investor Staff, updated Wed., Feb. 26, 3:35 PM
| This Slide: #58 of 100 |
Slide #58. Roadman Investments Corp. — CLOV Biopharma Corp.
Acquirer:
Roadman Investments Corp. (CVE:LITT.CA)
Acquiree:
CLOV Biopharma Corp.
Details:
Roadman Investments Corp. (TSXV: LITT)(FWB: 1QD)(OTC:RMANF) ("Roadman Investments" or the "Company") is pleased to announce that, further to its press release of February 12, 2020, it has now entered into a Definitive Agreement (the "Agreement") pursuant to which it has acquired all of the issued and outstanding shares of CLOV Biopharma Corp. ("CBP").
Roadman Investments is a global investment management, financial advisory and private equity firm focused on investing growth capital into private and public companies across the Pan-Pacific region in sectors including cleantech and renewable energy, natural resources, chemicals, agriculture and consumer services. As of June 30 2011, the fair value of Co.'s investments was C$2,233,964.
Open the LITT.CA Page at The Online Investor »
|
|||||||||
Open the LITT.CA Page at The Online Investor (in a new window) »
|
|
